Clinical Trial Update: Acarbose and Secondary Prevention After Coronary Stenting [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating acarbose for secondary prevention after coronary stenting has completed. The study includes patients with coronary artery disease and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Acarbose (acarbose)

Snippet

Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | Conditions: Glucose Metabolism Disorders, Coronary Artery Disease | Phase 3 | Status: COMPLETED